{
  "docId": "019de073-d546-7099-b69b-fc409bd054ba",
  "docSlug": "a8472da99eed55bdf1e59eb3c42372d9",
  "documentTitle": "Silo Pharma | Investor Presentation Deck | 24 slides",
  "authorId": "silo-pharma",
  "authorName": "Silo Pharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 24,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide outlines the market opportunity, technology, and specific applications for the SP-26 program.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-d546-7099-b69b-fc409bd054ba/9",
  "deckHref": "/decks/019de073-d546-7099-b69b-fc409bd054ba",
  "deckJsonHref": "/decks/019de073-d546-7099-b69b-fc409bd054ba.json",
  "deckAnchorHref": "/decks/019de073-d546-7099-b69b-fc409bd054ba#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.85,
        "y": 0.05
      },
      "kind": "image",
      "text": "SiloPharma Nasdaq: SILO",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f0c83342-8113-40b9-9de0-1785dd313694",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.35,
        "y": 0.5
      },
      "kind": "list",
      "text": "Technology: Joint Venture with Zylö Therapeutics, Inc. Clinical development of psilocybin using ZTI's Z-pod technology. Clinical development of Zylo's sustained release topical delivery system",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9db5cf5d-f792-42a8-b138-13c042b578a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "list",
      "text": "Market Opportunity: Fibromyalgia and multiple other indications",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf7af569-65c7-4c1c-87ba-8c5074d816b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.65,
        "y": 0.35
      },
      "kind": "list",
      "text": "Applications: Deliver ketamine or psilocybin in a time-released manner. Determining if time-release will diminish hallucinogenic effects of these psychedelics. Preclinical study underway shows Z-pod can hold and distribute ketamine. Efficacy study in animals underway",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa856390-9b37-4c08-a6a1-f23736a81cc6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.2,
        "x": 0.055,
        "y": 0.33
      },
      "kind": "paragraph",
      "text": "SP-26 Time-Released Psilocybin, Ketamine",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d650b2e-3db8-491f-b348-52f0d14c28d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.35,
        "x": 0.105,
        "y": 0.075
      },
      "kind": "title",
      "text": "Zylö Therapeutics Joint Venture",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb09d5cd-1441-4af7-955b-512e3fe6f3b0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 9,
      "beatId": "7eef8438-24a9-41be-8257-c3233f0d4ebf",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The solution is presented in the Zylö Therapeutics Joint Venture and UMB License Agreement sections",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}